A Neurosurgeon's Perspective on the Early Clinical Experience With GammaTile Therapy at an NCI-Designated Cancer Center

A Neurosurgeon’s Perspective on the Early Clinical Experience With GammaTile Therapy at an NCI-Designated Cancer Center

Dr. Kimberly Bojanowski Hoang of Emory University describes their experience with GammaTile Therapy, including a product overview, patient selection criteria, procedural workflow, and early clinical outcomes.

Blog

A Neurosurgeon’s Perspective on the Early Clinical Experience With GammaTile Therapy at an NCI-Designated Cancer Center

You may also like:

What’s Happening in Health: Liz Bonis is Joined by a Team to Talk About Brain Tumor Surgery

Westchester Medical Center First in Region to Offer Brain Tumor Therapy That Can Slow Tumor Progression

West Cancer Center & Research Institute achieves ELITE status for innovative brain tumor treatment